All In Biotech

Drug Trial Radar · NCT00482209

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

Last checked: Nov 20, 2026Latest source record: Oct 12, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,220 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,220

Planned (sponsor's estimate)

Start

May 2007

Primary completion

Oct 2009

Study completion Oct 2009

Sponsor

Lead sponsor
Gynuity Health ProjectsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 5, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This double-blind, randomized study will compare the efficacy and acceptability of mifepristone 200mg followed in 36-48 hours by 400mcg or 800mcg of buccal misoprostol (i.e., in the cheeks) for termination of pregnancy in women up to 63 days LMP.

Conditions

  • Induced Abortion

Interventions

  • Mifepristone, misoprostolDrug

    200mg mifepristone followed by 400mcg misoprostol 36-48 hours later

  • mifepristone, misoprostolDrug

    200mg mifepristone followed by 800mcg misoprostol 36-48 hours later

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Need for surgical completion for ongoing viable pregnancies at follow up visit (Study day 12-15) or for incomplete abortion at extended follow up visit (Study day (19-22).Time frame: Study day 12-15 for ongoing viable pregnancies or Study day 19-22 for incomplete abortion at extended follow up visit

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Maternity House #2

    Tbilisi, Georgia

  • Maternity House #4

    Tbilisi, Georgia

  • Zhordania Institute of Human Reproduction

    Tbilisi, Georgia

  • Hocmon Hospital

    Ho Chi Minh City, Vietnam

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.